Abstract
Main text(Molecular Therapy: Nucleic Acids 22, 696–707; December 2020) Molecular Therapy Nucleic Acids is retracting this article at the request of the editor-in-chief. Concerns regarding image reuse across publications were mentioned on a PubPeer thread (https://pubpeer.com/publications/5DC76F377D5DF7BBF8931F0AC994F4). Readers drew attention to similarities between figures in this article and an article in Journal of Pineal Research (Zhou et al., 2018, J. Pineal Res. 65, e12503, https://doi.org/10.1111/jpi.12503). Image analysis performed by the editorial office revealed evidence of image duplication involving Figures 1E, 1H, and 7B of the Molecular Therapy Nucleic Acids article. This reuse of data without appropriate attribution represents a severe abuse of the scientific publishing system. The original notice of retraction was undeliverable to co-author David Mui. None of the authors responded to the notice of retraction.
| Original language | English (US) |
|---|---|
| Article number | 102637 |
| Journal | Molecular Therapy Nucleic Acids |
| Volume | 36 |
| Issue number | 3 |
| DOIs |
|
| State | Published - Sep 9 2025 |
Bibliographical note
Publisher Copyright:© 2025 The Author(s)
Fingerprint
Dive into the research topics of 'Retraction Notice to: SERCA Overexpression Improves Mitochondrial Quality Control and Attenuates Cardiac Microvascular Ischemia-Reperfusion Injury (Molecular Therapy - Nucleic Acids (2020) 22 (696–707), (S2162253120302845), (10.1016/j.omtn.2020.09.013))'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS